← Open Payments lookup

SARA RICHESON: Open Payments

NPI 1720566797 · NEWBURGH, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,273 in 57 payments from 16 companies in 2025. Trend: 2023 $1,410 · 2024 $1,643 · 2025 $1,273

Food & beverage: $1,273
CompanyPaymentsAmount
ABBVIE INC.16$291
Madrigal Pharmaceuticals5$186
Takeda Pharmaceuticals U.S.A., Inc.8$183
Salix Pharmaceuticals, a division of Bausch Health US, LLC4$93
Janssen Biotech, Inc.3$65
Lilly USA, LLC3$62
GENZYME CORPORATION2$57
Regeneron Healthcare Solutions, Inc.2$50
Braintree Laboratories, Inc.2$43
Gilead Sciences, Inc.2$42

Products named: REZDIFFRA, RINVOQ, ENTYVIO, DUPIXENT, XIFAXAN, TREMFYA, OMVOH, SKYRIZI.

Industry payments across IN — which companies pay providers there.